Market Share of France Diabetes Drugs Industry
The France Diabetes Drugs Market is fragmented, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, and AstraZeneca, holding a presence in the region. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones. These measures taken by the market players will ensure a competitive marketplace, forcing companies to experiment with new technologies.
France Diabetes Drugs Market Leaders
AstraZeneca
Boehringer Ingelheim
Sanofi Aventis
Novo Nordisk A/S
Eli Lilly and Company
*Disclaimer: Major Players sorted in no particular order
